text: Our financial performance earned recognition from*Investors Business Daily*, which ranked Atrion sixth 
  
  on its list of Market-Leading Medical Stocks in November 2003. During the year, our stock price more than 
  
  doubled, ending the year at $45.44, up from $22.50 at year-end 2002. Over the last five years, our stock price 
  
  has increased by 468 percent. 